11.08.2012 Views

QF0159 Marketing Release Record

QF0159 Marketing Release Record

QF0159 Marketing Release Record

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Human lymph node, follicular lymphoma; immunohistochemical staining for Bcl-6 using<br />

NCL-L-Bcl-6-564. Note intense nuclear staining of malignant lymphocytes. Paraffin section.<br />

Novocastra Bcl-10 Oncoprotein<br />

Clone DAA22<br />

1 mL lyophilized NCL-Bcl-10 W<br />

Antigen Background<br />

RUO*<br />

Bcl-10 oncoprotein is an apoptotic regulatory molecule identified as a result<br />

of its direct involvement in the translocation event t(1;14) (p22;q32) of mucosaassociated<br />

lymphoid tissue (MALT) lymphomas. MALT lymphomas are the<br />

most common subset of extranodal non-Hodgkin’s lymphomas. Wild type Bcl-<br />

10 oncoprotein promotes apoptosis under normal circumstances and induces<br />

NF-kappaB activation. Mutated forms of Bcl-10 oncoprotein have been found<br />

to be associated with many common forms of cancer. The N-terminal region<br />

of Bcl-10 oncoprotein encodes a caspase recruitment domain (CARD) which<br />

is homologous with regions of several proteins involved in apoptosis. Several<br />

mutation events lead to the Bcl-10 oncoprotein becoming truncated in the<br />

region immediately downstream of the CARD. The truncated molecules do not<br />

induce apoptosis and gain a transforming function that is not present in the<br />

full length molecule. These truncated molecules are, therefore, thought to be<br />

important factors that encourage cell proliferation during tumor<br />

development. In normal tissues, Bcl-10 oncoprotein is expressed only in<br />

breast and lymphoid tissues with staining predominantly found in the<br />

cytoplasm.<br />

Product Specific Information<br />

NCL-Bcl-10 is raised to the majority of the coding region of the Bcl-10<br />

oncoprotein.<br />

Western blot: detection of Bcl-10 oncoprotein (32 kD) using NCL-Bcl-10. Lane A, molecular<br />

weight markers. Lane B, A549 cell line immunoblotted with NCL-Bcl-10.<br />

Novocastra Bcl-w<br />

Clone 6C1<br />

1 mL lyophilized NCL-Bcl-w P (HIER) W<br />

Bcl-w belongs to the Bcl-2 family of proteins and promotes cell survival,<br />

whereas other members such as bak and bax are antagonists and promote<br />

apoptosis. The Bcl-w gene is highly conserved between mice and man. Bclw<br />

protein is reported to be found in a diverse range of tissues including<br />

cerebellum, hippocampus, colon, liver, heart, stomach, skeletal muscle,<br />

testis and placenta. It is also expressed in most myeloid and a few lymphoid<br />

cell lines including those of macrophage megakaryocytic and erythroid<br />

origin. It is not expressed on B and T cell lines. Bcl-w is apparently<br />

dispensable in normal development and function of most organs but is<br />

essential for spermatogenesis.<br />

Human brain, normal adult cerebellum: immunohistochemical staining for Bcl-w protein using<br />

NCL-Bcl-w. Note intense cytoplasmic staining of Purkinje cells and their processes. Paraffin<br />

section.<br />

Novocastra bcl-x<br />

Clone NC1<br />

1 mL lyophilized NCL-bcl-x FP<br />

RUO*<br />

RUO*<br />

Bcl-x has homology with and is a member of the Bcl-2 family of proteins.<br />

Bcl-x can function as a regulator of cell death independently of bcl-2.<br />

Differential splicing of the bcl-x mRNA produces short and long variants<br />

known as bcl-x s and bcl-x L . These variants have different functions. Bcl-x<br />

immunoreactivity has been demonstrated in many cell types and like bcl-2,<br />

has been localized to the cytosol associated with mitochondria. Bcl-x has<br />

been demonstrated to be immunohistochemically detected in plasma cells,<br />

activated lymphocytes in interfollicular areas and a small number of<br />

lymphocytes within germinal centers. It has also been reported in Reed<br />

Sternberg cells in about 86 percent of Hodgkin's disease cases. In normal<br />

tissues, bcl-x expression has been reported in cortical thymocytes,<br />

megakaryocytes, red blood cell precursors and some types of differentiating<br />

myeloid cells in bone marrow as well as spermatocytes and spermatids in<br />

the testes. It is also found in mammary epithelial cells, secretory and basal<br />

epithelial cells of the prostate, gastrointestinal epithelial cells and<br />

differentiated keratinocytes in the upper layers of the epidermis (but not in<br />

basal cells).<br />

F Frozen I Immunofluorescence E Electron microscopy<br />

P Paraffin C Flow cytometry O Other applications<br />

W Western blotting<br />

/25<br />

Primary Antibodies

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!